Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

INMD vs ISRG vs SYK vs MDT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
INMD
InMode Ltd.

Medical - Devices

HealthcareNASDAQ • IL
Market Cap$882M
5Y Perf.-5.0%
ISRG
Intuitive Surgical, Inc.

Medical - Instruments & Supplies

HealthcareNASDAQ • US
Market Cap$161.07B
5Y Perf.+134.6%
SYK
Stryker Corporation

Medical - Devices

HealthcareNYSE • US
Market Cap$112.69B
5Y Perf.+50.3%
MDT
Medtronic plc

Medical - Devices

HealthcareNYSE • IE
Market Cap$99.94B
5Y Perf.-20.9%

INMD vs ISRG vs SYK vs MDT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
INMD logoINMD
ISRG logoISRG
SYK logoSYK
MDT logoMDT
IndustryMedical - DevicesMedical - Instruments & SuppliesMedical - DevicesMedical - Devices
Market Cap$882M$161.07B$112.69B$99.94B
Revenue (TTM)$375M$10.58B$25.12B$35.48B
Net Income (TTM)$87M$2.98B$3.25B$4.61B
Gross Margin77.8%66.3%63.5%61.9%
Operating Margin21.3%30.5%22.4%17.9%
Forward P/E9.6x43.8x19.6x14.1x
Total Debt$13M$303M$14.86B$28.52B
Cash & Equiv.$303M$3.37B$4.01B$2.22B

INMD vs ISRG vs SYK vs MDTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

INMD
ISRG
SYK
MDT
StockMay 20May 26Return
InMode Ltd. (INMD)10095.0-5.0%
Intuitive Surgical,… (ISRG)100234.6+134.6%
Stryker Corporation (SYK)100150.3+50.3%
Medtronic plc (MDT)10079.1-20.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: INMD vs ISRG vs SYK vs MDT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MDT leads in 3 of 7 categories, making it the strongest pick for capital preservation and lower volatility and dividend income and shareholder returns. InMode Ltd. is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. ISRG also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
INMD
InMode Ltd.
The Value Pick

INMD is the #2 pick in this set and the best alternative if valuation efficiency is your priority.

  • PEG 0.97 vs MDT's 36.00
  • Lower P/E (9.6x vs 14.1x), PEG 0.97 vs 36.00
  • -2.1% vs SYK's -22.5%
Best for: valuation efficiency
ISRG
Intuitive Surgical, Inc.
The Growth Play

ISRG is the clearest fit if your priority is growth exposure and long-term compounding.

  • Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
  • 5.5% 10Y total return vs SYK's 187.1%
  • Lower volatility, beta 1.02, Low D/E 1.7%, current ratio 4.87x
  • 20.5% revenue growth vs INMD's -6.2%
Best for: growth exposure and long-term compounding
SYK
Stryker Corporation
The Lower-Volatility Pick

SYK lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
MDT
Medtronic plc
The Income Pick

MDT carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 36 yrs, beta 0.47, yield 3.6%
  • Beta 0.47, yield 3.6%, current ratio 1.85x
  • Beta 0.47 vs INMD's 1.04
  • 3.6% yield, 36-year raise streak, vs SYK's 1.1%, (2 stocks pay no dividend)
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthISRG logoISRG20.5% revenue growth vs INMD's -6.2%
ValueINMD logoINMDLower P/E (9.6x vs 14.1x), PEG 0.97 vs 36.00
Quality / MarginsISRG logoISRG28.2% margin vs SYK's 12.9%
Stability / SafetyMDT logoMDTBeta 0.47 vs INMD's 1.04
DividendsMDT logoMDT3.6% yield, 36-year raise streak, vs SYK's 1.1%, (2 stocks pay no dividend)
Momentum (1Y)INMD logoINMD-2.1% vs SYK's -22.5%
Efficiency (ROA)MDT logoMDT175.8% ROA vs SYK's 6.9%, ROIC 6.0% vs 11.4%

INMD vs ISRG vs SYK vs MDT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

INMDInMode Ltd.
FY 2025
Capital Equipment
100.0%$289M
ISRGIntuitive Surgical, Inc.
FY 2025
Instruments and Accessories
59.8%$6.0B
Systems
24.6%$2.5B
Services
15.6%$1.6B
SYKStryker Corporation
FY 2025
MedSurg
62.3%$15.6B
Orthopaedics
37.7%$9.5B
MDTMedtronic plc
FY 2025
Cardiac and Vascular Group
37.3%$12.5B
Neuroscience Group
29.4%$9.8B
Medical Surgical
25.1%$8.4B
Diabetes Group
8.2%$2.8B

INMD vs ISRG vs SYK vs MDT — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLISRGLAGGINGSYK

Income & Cash Flow (Last 12 Months)

ISRG leads this category, winning 4 of 6 comparable metrics.

MDT is the larger business by revenue, generating $35.5B annually — 94.7x INMD's $375M. ISRG is the more profitable business, keeping 28.2% of every revenue dollar as net income compared to SYK's 12.9%. On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
RevenueTrailing 12 months$375M$10.6B$25.1B$35.5B
EBITDAEarnings before interest/tax$81M$3.8B$6.3B$9.4B
Net IncomeAfter-tax profit$87M$3.0B$3.2B$4.6B
Free Cash FlowCash after capex$91M$2.8B$4.3B$5.4B
Gross MarginGross profit ÷ Revenue+77.8%+66.3%+63.5%+61.9%
Operating MarginEBIT ÷ Revenue+21.3%+30.5%+22.4%+17.9%
Net MarginNet income ÷ Revenue+23.3%+28.2%+12.9%+13.0%
FCF MarginFCF ÷ Revenue+24.2%+26.8%+17.1%+15.2%
Rev. Growth (YoY)Latest quarter vs prior year+5.3%+23.0%+11.4%+8.8%
EPS Growth (YoY)Latest quarter vs prior year-30.8%+18.8%+56.0%-11.9%
ISRG leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

INMD leads this category, winning 7 of 7 comparable metrics.

At 9.7x trailing earnings, INMD trades at a 83% valuation discount to ISRG's 57.6x P/E. Adjusting for growth (PEG ratio), INMD offers better value at 0.98x vs MDT's 36.00x — a lower PEG means you pay less per unit of expected earnings growth.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
Market CapShares × price$882M$161.1B$112.7B$99.9B
Enterprise ValueMkt cap + debt − cash$593M$158.0B$123.5B$126.2B
Trailing P/EPrice ÷ TTM EPS9.73x57.62x35.03x21.60x
Forward P/EPrice ÷ next-FY EPS est.9.64x43.84x19.62x14.13x
PEG RatioP/E ÷ EPS growth rate0.98x2.65x2.36x36.00x
EV / EBITDAEnterprise value multiple6.88x43.62x20.31x14.32x
Price / SalesMarket cap ÷ Revenue2.38x16.00x4.49x2.98x
Price / BookPrice ÷ Book value/share1.33x9.17x5.02x2.08x
Price / FCFMarket cap ÷ FCF10.46x64.67x26.31x19.28x
INMD leads this category, winning 7 of 7 comparable metrics.

Profitability & Efficiency

ISRG leads this category, winning 6 of 9 comparable metrics.

ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $9 for MDT. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to SYK's 0.66x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs INMD's 3/9, reflecting solid financial health.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
ROE (TTM)Return on equity+13.3%+16.9%+15.0%+9.4%
ROA (TTM)Return on assets+11.8%+14.8%+6.9%+175.8%
ROICReturn on invested capital+13.5%+15.0%+11.4%+6.0%
ROCEReturn on capital employed+12.1%+16.5%+13.0%+7.5%
Piotroski ScoreFundamental quality 0–93666
Debt / EquityFinancial leverage0.02x0.02x0.66x0.59x
Net DebtTotal debt minus cash-$289M-$3.1B$10.8B$26.3B
Cash & Equiv.Liquid assets$303M$3.4B$4.0B$2.2B
Total DebtShort + long-term debt$13M$303M$14.9B$28.5B
Interest CoverageEBIT ÷ Interest expense6.72x9.08x
ISRG leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

ISRG leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ISRG five years ago would be worth $15,873 today (with dividends reinvested), compared to $3,613 for INMD. Over the past 12 months, INMD leads with a -2.1% total return vs SYK's -22.5%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.4% vs INMD's -26.4% — a key indicator of consistent wealth creation.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
YTD ReturnYear-to-date-5.9%-19.3%-15.2%-18.1%
1-Year ReturnPast 12 months-2.1%-15.4%-22.5%-2.8%
3-Year ReturnCumulative with dividends-60.2%+49.6%+5.5%-4.2%
5-Year ReturnCumulative with dividends-63.9%+58.7%+21.5%-27.7%
10-Year ReturnCumulative with dividends+105.0%+554.2%+187.1%+26.5%
CAGR (3Y)Annualised 3-year return-26.4%+14.4%+1.8%-1.4%
ISRG leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — INMD and MDT each lead in 1 of 2 comparable metrics.

MDT is the less volatile stock with a 0.47 beta — it tends to amplify market swings less than INMD's 1.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. INMD currently trades 83.2% from its 52-week high vs SYK's 72.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
Beta (5Y)Sensitivity to S&P 5001.04x1.02x0.55x0.47x
52-Week HighHighest price in past year$16.74$603.88$404.87$106.33
52-Week LowLowest price in past year$12.72$427.84$289.91$77.16
% of 52W HighCurrent price vs 52-week peak+83.2%+75.1%+72.7%+73.3%
RSI (14)Momentum oscillator 0–10039.842.424.327.3
Avg Volume (50D)Average daily shares traded804K1.8M2.1M7.8M
Evenly matched — INMD and MDT each lead in 1 of 2 comparable metrics.

Analyst Outlook

MDT leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: INMD as "Buy", ISRG as "Buy", SYK as "Buy", MDT as "Buy". Consensus price targets imply 40.5% upside for MDT (target: $110) vs 14.9% for INMD (target: $16). For income investors, MDT offers the higher dividend yield at 3.57% vs SYK's 1.14%.

MetricINMD logoINMDInMode Ltd.ISRG logoISRGIntuitive Surgica…SYK logoSYKStryker Corporati…MDT logoMDTMedtronic plc
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$16.00$622.60$403.69$109.50
# AnalystsCovering analysts11555049
Dividend YieldAnnual dividend ÷ price+1.1%+3.6%
Dividend StreakConsecutive years of raises3436
Dividend / ShareAnnual DPS$3.36$2.78
Buyback YieldShare repurchases ÷ mkt cap+14.5%+1.4%0.0%+3.2%
MDT leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). INMD leads in 1 (Valuation Metrics). 1 tied.

Best OverallIntuitive Surgical, Inc. (ISRG)Leads 3 of 6 categories
Loading custom metrics...

INMD vs ISRG vs SYK vs MDT: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is INMD or ISRG or SYK or MDT a better buy right now?

For growth investors, Intuitive Surgical, Inc.

(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -6. 2% for InMode Ltd. (INMD). InMode Ltd. (INMD) offers the better valuation at 9. 7x trailing P/E (9. 6x forward), making it the more compelling value choice. Analysts rate InMode Ltd. (INMD) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — INMD or ISRG or SYK or MDT?

On trailing P/E, InMode Ltd.

(INMD) is the cheapest at 9. 7x versus Intuitive Surgical, Inc. at 57. 6x. On forward P/E, InMode Ltd. is actually cheaper at 9. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: InMode Ltd. wins at 0. 97x versus Medtronic plc's 36. 00x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — INMD or ISRG or SYK or MDT?

Over the past 5 years, Intuitive Surgical, Inc.

(ISRG) delivered a total return of +58. 7%, compared to -63. 9% for InMode Ltd. (INMD). Over 10 years, the gap is even starker: ISRG returned +554. 2% versus MDT's +26. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — INMD or ISRG or SYK or MDT?

By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.

47β versus InMode Ltd. 's 1. 04β — meaning INMD is approximately 123% more volatile than MDT relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 66% for Stryker Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — INMD or ISRG or SYK or MDT?

By revenue growth (latest reported year), Intuitive Surgical, Inc.

(ISRG) is pulling ahead at 20. 5% versus -6. 2% for InMode Ltd. (INMD). On earnings-per-share growth, the picture is similar: Medtronic plc grew EPS 30. 8% year-over-year, compared to -36. 4% for InMode Ltd.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — INMD or ISRG or SYK or MDT?

Intuitive Surgical, Inc.

(ISRG) is the more profitable company, earning 28. 4% net margin versus 12. 9% for Stryker Corporation — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus 17. 8% for MDT. At the gross margin level — before operating expenses — INMD leads at 78. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is INMD or ISRG or SYK or MDT more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, InMode Ltd. (INMD) is the more undervalued stock at a PEG of 0. 97x versus Medtronic plc's 36. 00x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, InMode Ltd. (INMD) trades at 9. 6x forward P/E versus 43. 8x for Intuitive Surgical, Inc. — 34. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MDT: 40. 5% to $109. 50.

08

Which pays a better dividend — INMD or ISRG or SYK or MDT?

In this comparison, MDT (3.

6% yield), SYK (1. 1% yield) pay a dividend. INMD, ISRG do not pay a meaningful dividend and should not be held primarily for income.

09

Is INMD or ISRG or SYK or MDT better for a retirement portfolio?

For long-horizon retirement investors, Stryker Corporation (SYK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

55), 1. 1% yield, +187. 1% 10Y return). Both have compounded well over 10 years (SYK: +187. 1%, INMD: +105. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between INMD and ISRG and SYK and MDT?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: INMD is a small-cap deep-value stock; ISRG is a mid-cap high-growth stock; SYK is a mid-cap quality compounder stock; MDT is a mid-cap income-oriented stock. SYK, MDT pay a dividend while INMD, ISRG do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

INMD

Quality Mega-Cap Compounder

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 13%
Run This Screen
Stocks Like

ISRG

High-Growth Quality Leader

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 11%
  • Net Margin > 16%
Run This Screen
Stocks Like

SYK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Stocks Like

MDT

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform INMD and ISRG and SYK and MDT on the metrics below

Revenue Growth>
%
(INMD: 5.3% · ISRG: 23.0%)
Net Margin>
%
(INMD: 23.3% · ISRG: 28.2%)
P/E Ratio<
x
(INMD: 9.7x · ISRG: 57.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.